Nikki Hafezi-Kristoffersen, MAS IP ETHZ, CEO of the ELZA Institute and executive at the MESCA Foundation, recently visited the Bukhara State Medical Institute (BSMI).
Our latest review on corneal cross-linking (CXL), published in Progress in Retinal and Eye Research, explores its evolution, advanced protocols like ELZA-PACE, and clinical applications.
During Swiss Days 2024 in Tashkent, the ELZA Institute’s CEO, Nikki L. Hafezi, led a keratoconus screening initiative that identified critical cases and strengthened Swiss-Uzbek collaborations. The event, featured on Zo’r TV, highlights ELZA’s global healthcare impact.
A significant part of the symposium was dedicated to showcasing collaborative initiatives between Switzerland and Uzbekistan, particularly in healthcare. One example was a keratoconus screening initiative led by Ms. Nikki Hafezi, ELZA’s CEO, and a graduate of ETH Zürich and the University of Bern. This project, undertaken with local NGOs, provided vision screenings to 117 families, identifying three children with keratoconus. These children received further medical consultations and guidance for managing the condition.
Central Asian University (CAU) recently hosted a highly anticipated guest lecture on “Enterprising Ophthalmology,” featuring ELZA’s CEO and CMO, Nikki and Farhad Hafezi.
Nikki Hafezi, CEO of the ELZA Institute, was interviewed by The Ophthalmologist about transforming ophthalmic care in Central Asia, focusing on accessible, high-quality eye care through initiatives like the National Eye Institute in Uzbekistan.
On August 12, 2023, at Humo Arena, Tashkent, 63 Down syndrome children were screened for keratoconus under Nikki Hafezi’s leadership. Discover the importance of early detection.
Nikki Hafezi, a partner of MESCA Foundation, is leading healthcare transformation in Uzbekistan. MESCA, founded in 2021 by Bakhtiyor Fazylov, focuses on medical education, training, and research. It aims to enhance ophthalmological care, particularly addressing keratoconus, a significant cause of preventable blindness in children. MESCA’s initiatives include training local healthcare professionals and collaborating with institutions like the Andijan State Medical Institute to improve medical practice and education.
Nikki Hafezi’s recent visit to Tashkent’s School No.178, the first public school in Uzbekistan to join the K-MAP study, emphasized the importance of keratoconus prevalence research and the inspiring potential of youth. Her engagement highlights the vital link between education and health initiatives.
Our CEO’s keratoconus screening in Uzbekistan underscores the importance of early detection and treatment, in collaboration with local medical professionals.
